125 related articles for article (PubMed ID: 38796112)
1. A high-throughput cell-based screening method for Zika virus protease inhibitor discovery.
Anindita PD; Otsuka Y; Lattmann S; Ngo KH; Liew CW; Kang C; Harris RS; Scampavia L; Spicer TP; Luo D
SLAS Discov; 2024 May; ():100164. PubMed ID: 38796112
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses.
Shin HJ; Kim MH; Lee JY; Hwang I; Yoon GY; Kim HS; Kwon YC; Ahn DG; Kim KD; Kim BT; Kim SJ; Kim C
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33800763
[TBL] [Abstract][Full Text] [Related]
3. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
[TBL] [Abstract][Full Text] [Related]
4. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
Akaberi D; Chinthakindi PK; Båhlström A; Palanisamy N; Sandström A; Lundkvist Å; Lennerstrand J
J Biomol Struct Dyn; 2020 Nov; 38(18):5526-5536. PubMed ID: 31880199
[TBL] [Abstract][Full Text] [Related]
5. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
[TBL] [Abstract][Full Text] [Related]
6. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
7. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
8. Identification of a small compound that specifically inhibits Zika virus in vitro and in vivo by targeting the NS2B-NS3 protease.
Miao J; Yuan H; Rao J; Zou J; Yang K; Peng G; Cao S; Chen H; Song Y
Antiviral Res; 2022 Mar; 199():105255. PubMed ID: 35143853
[TBL] [Abstract][Full Text] [Related]
9. Identification of Theaflavin-3,3'-Digallate as a Novel Zika Virus Protease Inhibitor.
Cui X; Zhou R; Huang C; Zhang R; Wang J; Zhang Y; Ding J; Li X; Zhou J; Cen S
Front Pharmacol; 2020; 11():514313. PubMed ID: 33192499
[TBL] [Abstract][Full Text] [Related]
10. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel Zika virus NS3 protease inhibitors with different inhibition modes by integrative experimental and computational approaches.
Andrade MA; Mottin M; Sousa BKP; Barbosa JARG; Dos Santos Azevedo C; Lasse Silva C; Gonçalves de Andrade M; Motta FN; Maulay-Bailly C; Amand S; Santana JM; Horta Andrade C; Grellier P; Bastos IMD
Biochimie; 2023 Sep; 212():143-152. PubMed ID: 37088408
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of a novel inhibitor of the ZIKA virus NS2B/NS3 protease.
Xiong Y; Cheng F; Zhang J; Su H; Hu H; Zou Y; Li M; Xu Y
Bioorg Chem; 2022 Nov; 128():106109. PubMed ID: 36049322
[TBL] [Abstract][Full Text] [Related]
14. Increased activity of unlinked Zika virus NS2B/NS3 protease compared to linked Zika virus protease.
Kuiper BD; Slater K; Spellmon N; Holcomb J; Medapureddy P; Muzzarelli KM; Yang Z; Ovadia R; Amblard F; Kovari IA; Schinazi RF; Kovari LC
Biochem Biophys Res Commun; 2017 Oct; 492(4):668-673. PubMed ID: 28342876
[TBL] [Abstract][Full Text] [Related]
15. Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Irfan M; Naveed M; Bhinder MA; Ghani MU; Hussain N; Said ASA; Al Haddad AHI; Saleem M
Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679976
[TBL] [Abstract][Full Text] [Related]
16. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor.
Chan JF; Chik KK; Yuan S; Yip CC; Zhu Z; Tee KM; Tsang JO; Chan CC; Poon VK; Lu G; Zhang AJ; Lai KK; Chan KH; Kao RY; Yuen KY
Antiviral Res; 2017 May; 141():29-37. PubMed ID: 28185815
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
[TBL] [Abstract][Full Text] [Related]
18. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L
Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential ZIKV NS2B-NS3 protease inhibitors from
Thirumoorthy G; Tarachand SP; Nagella P; Veerappa Lakshmaiah V
J Biomol Struct Dyn; 2022; 40(21):11203-11215. PubMed ID: 34319220
[No Abstract] [Full Text] [Related]
20. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
Zephyr J; Rao DN; Johnson C; Shaqra AM; Nalivaika EA; Jordan A; Kurt Yilmaz N; Ali A; Schiffer CA
Bioorg Chem; 2023 Feb; 131():106269. PubMed ID: 36446201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
